ABSTRACT
Alzheimer's disease (AD) is a degenerative neurological disorder with unclear pathogenesis. Single-target drugs have very limited efficacy in treating AD, but synthetic multi-target drugs have poor efficacy and safety. Therefore, finding suitable natural multi-target drugs against AD is of great interest for research studies. We chose two flavonols, myricetin and morin, for the relevant study. In this study, we used microinjection of Aß1-42 oligomers into the CA1 region of rat hippocampus, combined with gavage of Aluminum chloride hexahydrate (AlCl3·6H2O) solution to establish AD rat models, and myricetin and morin were selected as intervening drugs to explore the protective effects against neurological impairment. Experimental results showed that myricetin or morin could reduce the production of Aß, Tubulin-associated unit (Tau), and Phosphorylated tubulin-associated unit (p-Tau), down-regulate the expression of relevant inflammatory factors, reduce hippocampal cell apoptosis in rats. There was a significant increase in the activity of adenosine triphosphatase, catalase, total superoxide dismutase, and the content of glutathione in the brain tissue. However, the content of malondialdehyde, inducible nitric oxide synthase, and the activity of acetylcholinesterase were decreased in the brain tissue. These two flavonols can regulate the imbalance of monoamine and amino acid neurotransmitter levels. In conclusion, Myricetin or morin can effectively improve learning and memory dysfunction in AD rats induced by Aß1-42/Al3+ through anti-oxidative stress and anti-apoptotic features.
Subject(s)
Alzheimer Disease , Amyloid beta-Peptides , Disease Models, Animal , Flavones , Flavonoids , Neuroprotective Agents , Peptide Fragments , Animals , Flavonoids/pharmacology , Flavonoids/therapeutic use , Alzheimer Disease/metabolism , Alzheimer Disease/drug therapy , Alzheimer Disease/chemically induced , Alzheimer Disease/pathology , Rats , Amyloid beta-Peptides/metabolism , Amyloid beta-Peptides/toxicity , Peptide Fragments/toxicity , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Male , Rats, Sprague-Dawley , Aluminum Chloride/toxicity , Hippocampus/drug effects , Hippocampus/metabolism , Oxidative Stress/drug effectsABSTRACT
This study provided the primary data of selected trace elements and rare earth elements from 120 samples of mantis shrimp Oratosquilla oratoria (O. oratoria) caught from three sites in the Shandong Province, China and evaluated the potential health risk of shrimp consumption from this region. The calculation of estimated daily intake (EDI), target hazard quotient (THQ) and total target hazard quotient (TTHQ) showed that the contents of all target TREs were below respective permitted limits recommended by China, with the exceptions of Cd and iAs levels. In addition to pollution, results indicated that TREs concentrations in O. oratoria were also impacted by characteristics of O. oratoria. The distribution patterns of REEs in O. oratoria did not differ from those in the sediment and other marine organisms, following the abundance rule. Consumption of O. oratoria from Shandong Province is potentially harmful to human health due to high levels of Cd and iAs.
Subject(s)
Metals, Heavy , Metals, Rare Earth , Trace Elements , Animals , China , Crustacea , Environmental Monitoring , Humans , Metals, Heavy/analysis , Risk Assessment , Seafood , Trace Elements/analysisABSTRACT
The study investigated the combined effect of 1,2-dimethyl-3-hydroxypyrid-4-one (DFP) and taurine on aluminum (Al) toxicity in cortex and blood of rats. The control group received 1 ml/kg/day saline solution for 8 weeks. Other animals were exposed to Al at a dose of 281.40 mg/kg/day orally for 4 weeks. Then, they were administered with 1 ml/kg/day saline solution, 400 mg/(kg·day) taurine, 13.82 mg/(kg·day) DFP, 27.44 mg/(kg·day) DFP, 400 mg/(kg·day) taurine +13.82 mg/(kg·day) DFP, and 400 mg/(kg·day) taurine +27.44 mg/(kg·day) DFP for 4 weeks. The changes in markers of oxidative stress, activities of antioxidant enzymes, and triphosphatase (ATPase) in the cortex and blood were determined. Administration of Al led to significant increase in the malondialdehyde (MDA) level and decrease in the activities of antioxidant enzymes, Na+K+-ATPase, Mg2+-ATPase, and Ca2+-ATPase in the cortex and blood, compared with the control group. DFP was observed to reverse alteration of these parameters except for Ca2+-ATPase activity. Treatment with taurine caused significant increase of GSH-Px activity and decrease of the MDA level in the cortex and serum and rise of Na+K+-ATPase in the blood. Effects of DFP combined with taurine were investigated and found to provide a more significant benefit than either drug alone. Combined intake of taurine and DFP could achieve an optimum effect of therapy for Al exposure.
